NovaMin Technology, Inc. (extinct)

NovaMin Technology, Inc. (extinct)

NovaMin Technology, Inc. (extinct)

Date Founded



13859 Progress Boulevard,Suite 600,Alachua, FL 32615

Type of Company



Medical Products & Equipment
Hospitals & Patient Services

Company Description

NovaMin Technology, Inc. provides tooth remineralization technology products and services. It offers NovaMin made from bioactive materials and a tooth re-mineralization technology which provides the teeth with essential minerals in ionic forms and supercharging the natural tooth. The company was founded in 2003 and is headquartered in Alachua, FL

Paths to NovaMin Technology, Inc.
Potential Connections via
Relationship Science
NovaMin Technology, Inc.
Recent Transactions
Details Hidden

GlaxoSmithKline Plc purchases NovaMin Technology, Inc. from Intersouth Advisors, Inc., HMC-Virginia, Inc.

Details Hidden

Intersouth Partners focuses on seed and early-stage investments in the information technology and life sciences sectors. They invest across the Southeastern US, primarily in the corridor from Baltimore through Florida, including Washington, DC, the Research Triangle region and Atlanta.Intersouth Partners prefers to be the lead or co-lead investor. They also prefer to participate in the first institutional round of financing. Initial investments range from $500,000 to $5 million with an average total investment of $12 million over the life of a company.The firm looks for companies with proven management teams and large growing markets. They also look for companies with a sustainable business model that is led by a realistic revenue model. Companies should have a unique and proprietary product, technology, service or market position and the potential for rapid growth and high margins. Intersouth Partners' investment horizon is 2 to 5 years.

Details Hidden

U.S. Biomaterials Corp. develops tissue structure and function restoring materials and devices. The company was founded in 1991 and is headquartered in Jacksonville, FL.

Details Hidden

HMC Virginia provides growth capital to early-stage information technology and healthcare companies in the Southeastern US. Particular sectors of interest include: communications software and services, enterprise/applications software, communications equipment, semiconductors, transaction processing, therapeutics, biotechnology platforms, diagnostics and medical devices, healthcare information technology and healthcare services and outsourcing. The firm concentrates on companies with experienced management teams, large and growing target markets, recurring revenue business models, scalable operating platforms and attractive exit possibilities. Harbert Venture Partners invests in the first or second institutional rounds, with initial investment amounts between $500,000 and $2.5 million. They typically seek board representation on their portfolio companies' boards of directors.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by NovaMin Technology, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of NovaMin Technology, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and NovaMin Technology, Inc..